Key points are not available for this paper at this time.
This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with recommendations for drug approval.
Rand et al. (Mon,) studied this question.